Search results

Background: In a previous study, we explored real-world programmed death-ligand 1 (PD-L1) testing and treatment patterns for patients with advanced non-small cell lung cancer (NSCLC) in the era of immune-oncology. The present study aimed to investigate overall survival (OS) with PD-(L)1 inhibitors with longer-term follow-up in the Swedish setting. Materials and methods: Data were extracted from th

Microsoft Word - halvtid, blankett.doc Certificate, Halfway review for PhD-education Name of doctoral student: Personal identity number: Department: Email address: THE DOCTORAL STUDENT'S PERFORMANCE AT THE SEMINAR Component Comments and recommendation Written summary of the thesis project. Oral presentation. Discussion/handling of questions. ACTIVITY, PROGRESS AND QUALITY OF RESEARCH WORK Componen

https://www.intramed.lu.se/en/sites/intramed.lu.se.en/files/2024-11/Certificate%20half%20way%20review%20241126.pdf - 2026-06-06

Our ultimate research vision is to discover, develop and implement novel neuroprotective and neurorestorative therapies for neurological disorders such as Parkinson’s disease, Huntingtons disease and stroke. My group works with translational research that is tightly linked to clinical research questions. Our experimental focus is to understand neurovascular disease mechanisms. We examine the dysfu

https://www.geriatrik.lu.se/sites/geriatrik.lu.se/files/2025-10/Nyhetsbrev%20fra%CC%8An%20GA%CC%8AS-projektet%20december%202023.pdf - 2026-06-06

PowerPoint-presentation Header – Optional Introduction – should be maximum three lines. Olo que liciumque porem harum hiliquidis ium quo doloreped qui aperum doluptia perumen ditatestia qui volupta spedipsusam, te plab ipiet voluptusamus alibus ent lit aut qui aut placienem es aliberum sum ea aut harum sit apiciat invenda. Date: 2nd of October 2019 Time: 13.00–15.30 Place: Hörsalen, Pufendorfinsti

https://www.cec.lu.se/sites/cec.lu.se/files/affischmall_a3_cec_2019_eng.pptx - 2026-06-06

https://www.saco.se/globalassets/lokala-akademikerforeningar/privat/siemens-energy-ab/nyhetsbrev/asi-nyhetsbrev-0624.pdf - 2026-06-05

OBJECTIVE: To study long-term work disability before and after tumour necrosis factor (TNF)-antagonist therapy in patients with psoriatic arthritis (PsA). METHODS: Using the population-based South Swedish Arthritis Treatment Group Register, we identified 191 patients with PsA (median age 43 years, range 18-58 years, 54% men), who between January 2003 and December 2007 started treatment with adalim

MultiPark är ett translationellt forskningsnätverk som sträcker sig från preklinisk forskning till studier av livssituationer för patienter med Alzheimers och Parkinsons sjukdom samt relaterade hjärnsjukdomar. Vi syftar inte bara till att förbättra patienternas kroppsfunktion utan även deras aktivitet och delaktighet. MultiPark bygger på ett starkt samarbete mellan Lunds universitet och Skånes uniMultiPark (Multidisciplinary research focused on Parkinson's disease) is a translational programme that ranges from experimental pre-clinical research to studies on the life situation of patients with neurodegenerative disorders. Our programme not only aims at improving the overall function of patients, but also their acitivity and participation. This initiative relies on solid interactions betwee

Vår multidisciplinära forskning fokuserar på personer med neurodegenerativa sjukdomar (såsom Parkinsons sjukdom och kognitiva sjukdomar), inklusive personer som har en ökad risk att utveckla sådana sjukdomar. En tidig upptäckt möjliggör tidigt stöd och rehabilitering. Vår forskning identifierar tidiga tecken, konsekvenser, prognostiska faktorer och behov av åtgärder. Forskningen avser även att ökOur multidisciplinary research focus on people with neurodegenerative diseases (ND), such as Parkinson’s disease and major neurocognitive disorders (dementia). We also include people at risk of developing ND. Early detection facilitates timely support and rehabilitation. Our research aims to determine early signs, consequences, unmet needs, and prognostic factors. We also aim to gain an increased

Injectable Bioresorbable Organic Bioelectronics Neuropharmacology—our ambition is to supplement classical biochemical signaling with the modulation of bioelectricity using both ionic and electronic processes. We focus on organic electronics that self-assemble directly inside or near the nervous system to form electronic circuits that mimic its structure and organization, enabling seamless integrat

1 ClimBEco course (3 ECTS credits) Biodiversity and ecosystem services: science and practice September 17-22, 2023; Kullaberg Nature Reserve, Kullaberg, Sweden Sunday 17.09: Arrival day 16:00 Pick-up at Lund Central Station (group transit via minibus) 18.00-18:30 Welcome and introduction 18.30-19:30 Dinner Monday 18.09: Linking biodiversity and ecosystem services across scales 8.00-9.00 Breakfast

https://www.cec.lu.se/sites/cec.lu.se/files/2023-06/ClimBEco_BES_course2023_schedule_public_0.pdf - 2026-06-06

Artificial Intelligence in Cardiothoracic Science was funded 2006. Traditionally, medical decisions are based on the combined strength of clinical facts and the experience of the clinician. A growing understanding of the molecular, genetic and biochemical basis of diseases have greatly increased the degree of complexity in medical decision-making. To identify risk factors in medical registers, a nArtificial Intelligence in Cardiothoracic Science was funded 2006. Traditionally, medical decisions are based on the combined strength of clinical facts and the experience of the clinician. A growing understanding of the molecular, genetic and biochemical basis of diseases have greatly increased the degree of complexity in medical decision-making. To identify risk factors in medical registers, a n

Our research group on paediatric haematology is focused on bleeding- and coagulation disorders in children, in particular on haemophilia and venous thrombosis. Haemophilia A and B are hereditary, X chromosomal recessive bleeding disorders caused by deficiency or absence of coagulation factors VIII (FVIII) or IX (FIX) in the blood. The general aim of this part of the research program is to improve Our research group on paediatric haematology is focused on bleeding- and coagulation disorders in children, in particular on haemophilia and venous thrombosis. Haemophilia A and B are hereditary, X chromosomal recessive bleeding disorders caused by deficiency or absence of coagulation factors VIII (FVIII) or IX (FIX) in the blood. The general aim of this part of the research program is to improve